Form D · Biotechnology
Treeline Biosciences, Inc.
Watertown, MA · CIK 0001856619
Offering snapshot reported Sep 4, 2025 · SEC filing
- Reported sold
- $200M Offering amount: $250M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 4, 2025 | Initial | $200,099,964 | No comparison | 22 | SEC filing |
| Oct 17, 2024 | Initial | $421,779,808 | No comparison | 43 | SEC filing |
| Oct 11, 2022 | Initial | $261,266,523 | No comparison | 44 | SEC filing |
| Apr 30, 2021 | Initial | $211,669,568 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-556563
Source: Form D, filed Sep 4, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua H. Bilenker | Director, Executive, Promoter |
| David Bonita | Director |
| Kristina Burow | Director |
| Steven Elms | Director |
| Jeffrey Engelman | Director, Executive, Promoter |
| Aftab Kherani | Director |
| Avi Naider | Director |
| Ali Satvat | Director |
| David Schenkein | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
500 Arsenal St.
Watertown, MA, 02472
Watertown, MA, 02472